![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 21, 18489-18493, May 24, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Immunology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030
Received for publication, December 10, 2001, and in revised form, February 5, 2002
Nonsense-mediated decay (NMD) is an RNA
surveillance pathway that degrades mRNAs containing premature
termination codons (PTC). T-cell receptor (TCR) and immunoglobulin (Ig)
transcripts, which are encoded by genes that very frequently acquire
PTCs during lymphoid ontogeny, are down-regulated much more
dramatically in response to PTCs than are other known transcripts.
Another feature unique to TCR, Ig, and a subset of other mRNAs is
that they are down-regulated in response to nonsense codons in the
nuclear fraction of cells. This is paradoxical, as the only well
recognized entity that recognizes nonsense codons is the cytoplasmic
translation apparatus. Therefore, we investigated whether translation
is responsible for this nuclear-associated mechanism. We found that the
down-regulation of TCR- The nonsense-mediated decay
(NMD)1 pathway is a quality
control system that selectively eliminates mRNAs containing
premature termination codons (PTCs) in all organisms that have been
examined to date (1-8). PTCs result from random mutations and
biosynthetic errors (in transcription and RNA splicing) that can occur
in virtually any gene. PTCs are particularly common in TCR and Ig
genes, which frequently acquire frameshifts and nonsense mutations as a
result of the programmed rearrangements that occur during T- and
B-lymphocyte development, respectively (2). Without a surveillance
pathway to detect such PTC-bearing transcripts, lymphocytes would
accumulate and translate high levels of truncated proteins, some of
which may possess dominant-negative or deleterious gain-of-function properties (2, 3, 8-10).
Because the signal that triggers down-regulation is a nonsense codon,
it was anticipated that it would cause the decay of mRNAs in the
cytoplasm where the translation machinery is known to function. Indeed,
Saccharomyces cerevisiae mRNAs harboring nonsense codons
are degraded more rapidly than their wild-type counterparts in the
cytoplasm (3, 6, 7). Nonsense codons also destabilize many mammalian
and viral mRNAs in the cytoplasm fraction of mammalian cells (1, 4,
5, 11-14). However, a surprise was the finding that TCR- The apparent involvement of the nucleus in this nonsense codon-induced
event leads to the question of whether NMD requires translation or
instead uses another codon-scanning mechanism. Evidence that NMD
involves a mechanism with some features of translation includes its
requirement for an initiator ATG and its reversal by several different
protein synthesis inhibitors with different mechanisms of action
(cycloheximide, emitine, anisomycin, puromycin, pactamycin, and
poliovirus) (17-20). However, the requirement for an ATG does not
prove the involvement of conventional translation, and general protein
synthesis inhibitors could reverse NMD by a mechanism not involving a
blockade of mRNA scanning; for example, they could act by simply
depleting cells of one or more unstable proteins necessary for NMD.
Furthermore, the mechanism that down-regulates TCR and Ig transcripts
in response to nonsense codons may differ from that which acts on other transcripts.
In the present investigation, we investigated the role of translation
and ribosomes in the down-regulation of TCR- Plasmids--
Construct A ( Transfection, RNA Isolation, and RNase Protection
Analysis--
DNA constructs were transiently transfected into HeLa
cells using LipofectAMINE according to the manufacturer's instructions (Invitrogen). Total and nuclear RNA were isolated as described previously (28). TCR- A Stem Loop Reverses TCR-
To determine whether the down-regulation of TCR- TCR- An Initiator ATG and Surrounding Kozak Consensus Nucleotides Are
Essential for Optimal Down-regulation of TCR-
If conventional translation is responsible for TCR-
The nonsense codon-bearing constructs with the best- and least-matched
Kozak sequences (constructs N and P, respectively) differed in their
mRNA levels by almost 3-fold (Fig. 3B). In contrast, there was no significant difference in the level of mRNA expressed from constructs that had these same mutations but lacked a nonsense codon (constructs Q and R) (Fig. 3B). Thus, these Kozak
consensus sequence mutations do not have a general effect on mRNA
metabolism. We conclude that an optimal down-regulatory response to a
nonsense codon requires Kozak consensus nucleotides surrounding an
intact initiator ATG. Our finding that the match to the Kozak consensus sequence correlated with the ability to down-regulate TCR- The NMD Factor UPF2 Plays a Role in the Down-regulation of TCR-
To determine the role of hUPF2 in TCR- We have provided several lines of new evidence that the
down-regulation of TCR- The simplest interpretation of our IRES data is that the NMD
down-regulatory response requires a ribosome, although we cannot rule
out that a non-ribosomal entity was recruited by the IRES in our
experiments. To our knowledge, this is the first time that the
down-regulatory response to a nonsense codon has been shown to be
elicited by a 5' cap-independent mechanism. Several lines of evidence
support the view that the IRES we used drives cap-independent translation and blocks cap-dependent translation. First,
dicistronic mRNAs that contain the poliovirus IRES inserted between
two reporter cistrons efficiently translate the second cistron without
a requirement for ribosomes to traverse the first cistron (24). Second,
introduction of small lesions throughout the central portion of the
poliovirus IRES (region P) block cap-independent initiation (35).
Third, when the poliovirus IRES situated upstream of a reporter gene was debilitated by deletion or point mutation, translation of the
reporter gene was extinguished, indicating that this IRES does not
permit cap-dependent translation, probably because of its
strong secondary structure (36). Fourth, when the extensive stem
loop-rich region of the poliovirus IRES was deleted,
cap-dependent translation was now permitted
(37).
Collectively, our data strongly suggests that the translation apparatus
is responsible for scanning TCR- Our demonstration that nonsense codons down-regulate TCR- We thank Drs. Hal Dietz, Joshua Mendell
(Johns Hopkins University) and Hansjörg Hauser
(Braunschweig, Germany) for kindly providing the plasmids
pCMV-rent 2 and pSBC-1, 2, respectively. We also thank Drs. Nahum
Sonenberg (McGill University) and Peter Sarnow (Stanford University)
for helpful discussions. We also thank Beth Notzon and members of the
Wilkinson laboratory (all at M. D. Anderson Cancer Center) for
valuable comments on the manuscript.
*
This work was supported by National Institutes of Health
Grant GM 58595 and National Science Foundation Grant MCB-9808936.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Published, JBC Papers in Press, March 11, 2002, DOI 10.1074/jbc.M111781200
The abbreviations used are:
NMD, nonsense-mediated decay;
PTC, premature termination codons;
TCR, T-cell
receptor;
IRES, internal ribosome entry site;
hUPF2, human UPF2;
UTR, untranslated region;
RPA, RNase protection analysis.
A Quality Control Pathway That Down-regulates Aberrant T-cell
Receptor (TCR) Transcripts by a Mechanism Requiring UPF2 and
Translation*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
transcripts in response to nonsense codons
requires several features of translation, including an initiator ATG
and the ability to scan. We also found that optimal down-regulation
depends on a Kozak consensus sequence surrounding the initiator ATG and
that it can be initiated by an internal ribosome entry site,
neither of which has been demonstrated before for any other PTC-bearing mRNA. At least a portion of this down-regulatory response is
mediated by the NMD pathway as antisense hUPF2 transcripts increased
the levels of PTC-bearing TCR-
transcripts in the nuclear
fraction of cells. We conclude that a hUPF2-dependent RNA
surveillance pathway with translation-like features operating in the
nuclear fraction of cells prevents the expression of potentially
deleterious truncated proteins encoded by non-productively rearranged
TCR genes.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
, Ig-
,
and some other mammalian transcripts are down-regulated by nonsense
codons in the nuclear fraction of cells (1, 2, 4, 15, 16). Two
observations support such nuclear involvement. First, the decay rate of
such nonsense codon-containing mRNAs is not measurably different
from that of their wild-type counterparts in the cytoplasm (1, 2, 4).
Second, reductions in the mRNA level in the nuclear fraction of
cells mirror those seen in total or cytoplasmic RNA preparations (1, 2,
4).
transcripts harboring
nonsense codons using new approaches. Our results showed not only did
optimal down-regulation of TCR-
mRNA require an initiator ATG,
it also depended on key nucleotide residues surrounding the ATG that
are required for efficient translation. Such Kozak consensus sequences
are a signature feature of translatable open reading frames (21), which
strongly support a role for translation in TCR-
mRNA
down-regulation. We found that TCR-
down-regulation in response to
nonsense codons also had several other features of translation,
including the ability to be down-regulated by an internal ribosome
entry site (IRES), a cis element that specifically recruits
ribosomes for translation (22). Lastly, to determine whether TCR-
down-regulation in response to nonsense codons has features of classic
NMD, we examined the role of UPF2, which has been shown in S. cerevisiae to be required for NMD. Our antisense studies clearly
showed that the down-regulation of TCR-
transcripts depends on human
UPF2 (hUPF2). To our knowledge, this is the first time that hUPF2 has
been shown to be required for the down-regulation of any transcript in
response to nonsense codons in mammalian cells.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-290) contains a wild-type TCR-
gene with a full-length open reading frame (pAc/IF in Ref. 16). B and C
(
-367,
-368, respectively) are derivatives of A that contain
nonsense (TAA) and missense (TAC) mutations at codon 68 in the VDJ exon generated by site-specific mutagenesis, respectively. D, E, and F
(
-658,
-627, and
-617, respectively) each contain a stem loop
(
G
61 kcal/mol) identical to that previously shown to impede translation (23) at a site 42 nt upstream of the initiator ATG
in constructs B, C, and A, respectively. G (
-495) is a TCR-
minigene (containing L, VDJ, and a C2.1-C2.4 chimeric exon) cloned between the SalI and HindIII sites of the vector
pSBC-2-C4 (EV 147) (24). The TCR-
minigene in G is identical to the
one we previously described (construct C in Ref. 19) except that the JC
intron was shortened from 1021 nt to 358 nt by cutting out an internal
Eco 01091 fragment. H (
-496) is identical to G except it
has a TAA nonsense codon at codon 68. I (
-498) and J (
-497) were
prepared by inserting a 1.1-kb ClaI/NotI fragment
from pSBC-1-C2 (EV-147), which contains the type I poliovirus IRES (nt
1-628 of the 5'-untranslated region (UTR)) (24) between the
ClaI and NotI sites of G and H, respectively. K
(
-600) is identical to B except that it has mutated initiator ATGs
rendered defective as previously described (construct I in Ref. 19). L
(
-639) is a derivative of B that has only the VDJ exon initiator ATG mutated as previously described (construct H in Ref. 19). M, N, O, and
P (
-626,
-630,
-647, and
-665, respectively) are derivatives of construct L that contain point mutations in the Kozak
consensus sequences. Q (
-760) and R (
-756) are identical to N and
P, respectively, except that they lack PTCs. S (
-595) is a
derivative of A that contains a nonsense mutation (TAG) at codon 98 (in
the VDJ exon). The anti-UPF2 construct (G-407) was generated by
inserting a 0.5-kb hUPF2 fragment between the SalI and
BamHI sites of the pH
Apr-1-neo (EV-107) vector (26) such that it is in the antisense orientation with respect to the
-actin promoter. The hUPF2 fragment was a PCR product generated with the
primers MDA-720 (5'-CTGGGATCCCGAGCGCTGGAGTTGGTG-3') and MDA-703 (5'-CCTGTCGACGCTGAATGGATTCTTC-3') using the plasmid pCMV-rent 2 (G-314) (25) as the template. G-1F was prepared by inserting the human
-globin gene into the HindIII and BamHI sites
of EV-107. All mutations introduced in the constructs described above
were generated by site-specific mutagenesis (27).
mRNA levels were determined using a direct radioactivity scanner (Instant Imager; Packard Instruments, Downers Grove, IL). RNase protection analysis (RPA) and the riboprobes (TCR-
, neomycin,
-actin) used for this analysis were described previously (28). The 
globin riboprobe template is a 250-nt PCR
fragment containing 50 nt of the 3' end of human 
globin intron 2 and 200 nt of exon 3. The hUPF2 riboprobe template is a 189-nt hUPF2
3'-cDNA fragment. We determined that our RPA assay was quantitative
by performing titration experiments; increasing the amount of input RNA
linearly increased the level of the protected TCR-
bands, whereas
increasing the amount of riboprobe had no effect on the protected
bands, indicating that excess probe was present in the annealing
reaction (data not shown).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
Down-regulation in Response to a
Nonsense Codon--
To examine the role of translation in the
down-regulation of TCR-
mRNA in response to nonsense codons, we
transiently transfected TCR-
constructs into HeLa cells. We used
HeLa cells because they reproduce all aspects of the PTC-mediated
down-regulation of TCR-
transcripts that we have observed in stably
transfected T cells (16, 18, 28). A major advantage of HeLa cells over
T cells is they can be transiently transfected with sufficient
efficiency to permit analysis of the RNA products by RPA.
transcripts in
response to nonsense codons depends on a scanning process, we
introduced a stem loop in the 5'-UTR of a functionally rearranged V
8.1D
2J
2.3C
2 gene that we have used in past studies to examine the response to
nonsense codons (16, 18, 28-30). The stem loop that we introduced was
identical to that which has been shown in past studies to efficiently
inhibit 5' cap-dependent translation (23). Introduction of
this stem loop almost completely abolished the down-regulation of
TCR-
mRNA in response to a PTC (Fig.
1). Down-regulation was >25-fold without
the stem loop (compare construct B with A) and was reduced to ~2-fold
after addition of the stem loop (compare construct D with F). The stem
loop specifically prevented the down-regulatory response to a nonsense
mutation, as it had no effect on the level of mRNA that had a
silent mutation at the same site as the nonsense codon (constructs C
and E). We conclude that either translation or some other scanning
mechanism that reads across the 5'-UTR is required to trigger TCR-
mRNA down-regulation in response to a nonsense codon.

View larger version (44K):
[in a new window]
Fig. 1.
A stem loop reverses TCR-
down-regulation in response to a nonsense codon. RPA of
total cellular RNA (10 µg) isolated from HeLa cells transiently
transfected with the constructs is shown. Construct A consists of the L
and VDJ exons of a functionally rearranged
V
8.1D
2J
2.3
gene (labeled L
and
VDJ
, respectively) and four C region exons
(labeled C
2.1,
C
2.2, C
2.3,
and C
2.4). Constructs B and
C contain nonsense and missense mutations, respectively, at codon 68 but otherwise are identical to construct A. Constructs D, E, and F are
identical to B, C, and A, respectively, except that they contain a stem
loop in the 5'-UTR. Because all constructs also contain an independent
transcription unit encoding neomycin, neomycin (Neo)
mRNA levels were used as a measure of transfection efficiency. The
TCR-
mRNA band protected by the TCR-
probe is ~72 nt, which
is the size expected based on the positions of the splice sites in
TCR-
mRNA. Similar results were obtained in three independent
transfection experiments.
mRNA Down-regulation in Response to a Nonsense Codon
Can Be Initiated by an IRES--
To test whether ribosomes are
involved in the scanning event, we examined whether an IRES permitted
TCR-
down-regulation in response to a nonsense codon. To assess
this, we generated TCR-
minigene constructs with or without a type I
poliovirus IRES (31, 32). We found that introduction of a nonsense
codon caused 3-fold down-regulation of IRES-containing TCR-
transcripts (compare constructs I with J in Fig.
2), which is comparable with the amount
of down-regulation of many non-IRES-containing transcripts, including
those encoding triosephosphate isomerase and
-globin (18, 23).
Introduction of a nonsense codon in the IRES-lacking (control)
construct down-regulated TCR-
mRNA expression by 10-fold (compare construct G with H in Fig. 2). The ~3-fold higher degree of
down-regulation exhibited by the IRES-lacking TCR-
mRNA is consistent with previous studies showing that cap-dependent
translation is ~3-fold more efficient than poliovirus IRES-mediated
translation (24, 33).

View larger version (37K):
[in a new window]
Fig. 2.
TCR-
mRNA
down-regulation in response to a nonsense codon can be elicited by an
internal ribosome entry site (IRES). RPA of total cellular RNA (10 µg) isolated from HeLa cells transiently transfected with the
constructs is shown. Construct G is a TCR-
minigene composed of
three exons, including a chimeric C exon (labeled
C
) that has portions of the
C
2.1 and C
2.4
exons, driven by an MT7 retroviral promoter (24). Construct H is
identical to G except that it harbors a PTC at codon 68. Constructs I
and J are identical to G and H, respectively, except that an IRES was
inserted before the ATG start codon in the L exon. A plasmid expressing
the
-globin gene (G1-F) was cotransfected with the TCR-
constructs to permit measurement of transfection efficiency. Similar
results were obtained in at least three independent transfection
experiments.
Transcripts in
Response to a Nonsense Codon--
We previously showed that an
initiator ATG is essential for the down-regulation of transcripts
derived from a TCR-
minigene containing a PTC (19). We showed that
there are two ATGs that could trigger down-regulation in this minigene:
the normal initiator in the leader (L) exon and a downstream ATG in the
5' end of the variable region (VDJ) exon that is in frame with the L
exon ATG. Only mutation of both ATGs reversed TCR-
down-regulation
in response to a PTC (19). Here, we first examined whether an ATG was
needed for the down-regulation of transcripts from a full-length
version of this TCR-
gene. Mutation of the VDJ ATG had no
appreciable effect on TCR-
down-regulation (data not shown).
However, when the L ATG was also mutated (construct K), down-regulation
was almost completely reversed (compare construct B that has both the L
and VDJ ATGs intact with construct K that has both the L and VDJ ATGs
mutated) (Fig. 3A). We
conclude that the normal initiator ATG in the L exon is essential for
the robust down-regulation of full-length TCR-
transcripts in
response to a PTC when the alternative ATG in the VDJ exon is also
mutated so that it cannot be used as an alternative initiation
site.

View larger version (50K):
[in a new window]
Fig. 3.
An initiator ATG and surrounding Kozak
consensus nucleotides are essential for optimal down-regulation of
TCR-
transcripts in response to a nonsense
codon. RPA of total cellular RNA (10 µg) isolated from HeLa
cells transiently transfected with the constructs is shown. mRNA
levels were quantitated as described in Fig. 1. Similar results were
obtained in at least three independent transfection experiments.
A, mutation of both initiator ATGs reversed the
down-regulation of TCR-
transcripts bearing a PTC. The ATG in the L
exon is the normal translation start site; the ATG in the VDJ exon is
in the same reading frame as the L exon start codon. Construct K has
both ATGs mutated and has a PTC at codon 68. B, the Kozak
consensus sequence around the initiator ATG is required for optimal
down-regulation in response to a nonsense codon. Constructs N and P
have a PTC at codon 68, whereas constructs A, Q, and R have the normal
sense codon at this position. All constructs have a normal L exon ATG
and a mutated VDJ exon ATG. The sequences surrounding the L exon ATG in
each construct are indicated in Table I.
down-regulation
in response to nonsense codons, then both the initiator ATG and the
surrounding nucleotides known to be essential for efficient
translational initiation should be required for optimal down-regulation
(21). This issue has never been addressed before for any gene. To test
this, we mutated the nucleotides surrounding the L exon ATG in
constructs that had the VDJ exon ATG mutated to prevent alternative
initiation from this second initiator site. We found that mutation of
the two most critical Kozak consensus sequences required for
translation (purines at the
3 and +4 positions with respect to the
ATG) prevented a full down-regulatory response (compare mutated
construct P with the wild-type construct L; Table I). As expected, polysome analysis
demonstrated that this double mutation significantly inhibited
translation (data not shown). More subtle mutations that only
substituted one (not both) of the critical purines (constructs M and
O), and thus would be expected to only minimally inhibit translation,
had either no or only a modest inhibitory effect on down-regulation
(Table I). Inversely, a mutation that better matched the TCR-
sequence to the Kozak consensus sequence (construct N) triggered a
stronger down-regulatory response (Table I).
The effect of Kozak consensus sequence mutations on NMD
gene harboring
a PTC (TAA) at codon 68 in the VDJ exon. The Kozak consensus sequence
is GCCRCCATGGAT. R (R = A, G) and G are the most critical residues for start-site
recognition. The VDJ exon ATG in each construct was disrupted by
mutation, whereas the ATG in the L exon (shown) is intact. mRNA
levels were determined by RPA and normalization against neomycin
mRNA levels (as in Fig. 1). The values obtained reflect the average
and standard error from three to four experiments.
transcripts strongly supports the notion that the RNA surveillance
pathway responsible for this down-regulatory response involves translation.
Transcripts in the Nuclear Fraction of Cells--
Once we had obtained
several lines of evidence that translation is required for PTC-induced
down-regulation of TCR-
transcripts, we next assessed whether this
down-regulation is exerted using the NMD RNA surveillance pathway. We
considered the possibility that TCR and Ig transcripts use a pathway
distinct from NMD, as these mRNAs are transcribed from genes that
acquire PTCs much more frequently than do other genes, are
down-regulated more strongly in response to nonsense codons than are
other known transcripts, and may require a unique second signal to be
down-regulated (2, 29, 30). To examine the role of NMD, we assessed
whether TCR-
down-regulation required hUPF2. Although human UPF2 has
not been proven to be involved in mammalian NMD, its orthologues in
S. cerevisiae (Upf2) and Caenorhabditis
elegans (Smg3) have been shown to be essential for NMD (3, 6, 7).
Furthermore, tethering a hUPF2/MS2 fusion protein downstream of the
stop codon in
-globin mRNA triggers an NMD-like response in HeLa
cells (34).
down-regulation, we generated
an expression plasmid that transcribes antisense hUPF2 mRNA. This
anti-hUPF2 plasmid was cotransfected with TCR-
plasmids into HeLa
cells, followed by RPA of nuclear RNA from these cells. Cotransfection
of the anti-hUPF2 plasmid partially reversed the down-regulation of
PTC-bearing TCR-
transcripts in the nuclear fraction (Fig.
4A). This reversal was
specific for the transcript harboring the nonsense codon (construct S)
as its level was increased 4-fold, whereas the levels of the wild-type
transcript (construct A) were not altered (Fig. 4A).
Cotransfection of a control vector plasmid that lacked antisense hUPF2
sequences had no effect on TCR-
mRNA down-regulation (data not
shown). To determine the degree of inhibition caused by anti-hUPF2, we
examined hUPF2 mRNA levels by RPA. We found that cotransfection of
the antisense-hUPF2 construct significantly decreased the level of
endogenous hUPF2 mRNA (~3-fold) compared with its level after
cotransfection with a control vector-only plasmid (Fig. 4B).
We therefore conclude that hUPF2 participates in the down-regulation of
TCR-
transcripts in response to nonsense codons. To our knowledge,
this is the first demonstration that human UPF2 is essential for the
NMD response in mammalian cells.

View larger version (44K):
[in a new window]
Fig. 4.
hUPF2 plays a role in nonsense codon-induced
down-regulation of TCR-
transcripts in the
nuclear fraction of cells. RPA of total cellular RNA (10 µg)
isolated from HeLa cells transiently transfected with the constructs
shown. A, antisense hUPF2 reverses down-regulation of
TCR-
transcripts in response to a nonsense codon.
-globin
mRNA levels were used as a measure of transfection efficiency as
described in Fig. 2. Construct S is identical to construct A except
that the nonsense mutation (TAG) is at codon 98. The
anti-hUPF2 plasmid was cotransfected with constructs A and S in the
lanes shown. Similar results were obtained in three independent
transfection experiments. B, antisense hUPF2 decreases the
level of endogenous hUPF2 mRNA. The hUPF2 mRNA band protected
by the hUPF2 probe is ~190 nt. hUPF2 mRNA levels were determined
by normalizing against the level of endogenous
-actin transcripts.
Constructs A and S were cotransfected with either the anti-hUPF2
plasmid or a control vector-only plasmid. Similar results were obtained
in at least two independent transfection experiments.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
transcripts in response to nonsense codons requires translation even though it occurs in the nuclear fraction of
cells. We demonstrated that this down-regulation is mediated by an
initiator ATG-dependent scanning process that requires the Kozak consensus sequence for optimal down-regulation (Figs. 1 and 3).
This, along with our observation that the down-regulation can be
triggered by an IRES (Fig. 2) and that it is reversed by specific
suppressor tRNAs (19), strongly suggests that nonsense codons
down-regulate TCR-
transcripts by a mechanism that depends on translation.
mRNAs for nonsense codons. This
codon scanning could occur in the nucleus proper as recent evidence
suggests that ~10% of mammalian cell translation is coupled with
transcription in the nucleus (38). This notion is further supported by
evidence for coupled transcription and translation in lower eukaryotes
and the finding that charged tRNAs and some translation initiation and
elongation factors accumulate in the nucleus of mammalian cells
(38-40). Alternatively, nonsense codon scanning may be mediated by
cytoplasmic ribosomes that biochemically cofractionate with the
nucleus. Even though we purified nuclei using two detergents (Nonidet
P-40 and sodium deoxycholate) by a protocol that removes >97% of
cytoplasmic mRNA (16), it is possible that NMD occurs near the
nuclear membrane and thus copurifies with the nucleus (1, 41). This
cytoplasmic scanning model appears to apply to
-globin mRNA, as
it has been shown that specific blockade of cytoplasmic scanning by the
cytoplasmic RNA-binding protein aconitase reverses
-globin NMD
(42).
transcripts by a UPF2-dependent mechanism (Fig. 4)
demonstrates the involvement of the classic NMD RNA surveillance
pathway in this down-regulatory response. However, we were not able to
completely reverse TCR-
mRNA down-regulation, even when we
cotransfected high concentrations of anti-hUPF2 plasmid (data not
shown). This may reflect the limitations of antisense technology, but
it could also indicate that TCR-
transcripts are down-regulated by
two mechanisms, one that is hUPF2-dependent (the NMD RNA
surveillance pathway) and another that is hUPF2-independent.
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Dept. of Immunology,
Box 180, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. Tel.: 713-794-5526; Fax: 713-745-0846; E-mail: mwilkins@mail.mdanderson.org.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Maquat, L. E.
(2000)
in
Translational Control of Gene Expression
(Sonenberg, N.
, Hershey, J. W. B.
, and Mathews, M. B., eds)
, pp. 849-868, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
2.
Li, S.,
and Wilkinson, M. F.
(1998)
Immunity
8,
135-141[CrossRef][Medline]
[Order article via Infotrieve]
3.
Culbertson, M. R.
(1999)
Trends Genet.
15,
74-80[CrossRef][Medline]
[Order article via Infotrieve]
4.
Hentze, M. W.,
and Kulozik, A. E.
(1999)
Cell
96,
307-310[CrossRef][Medline]
[Order article via Infotrieve]
5.
Hilleren, P.,
and Parker, R.
(1999)
RNA
5,
711-719[Abstract]
6.
Jacobson, A.,
and Peltz, S. W.
(2000)
in
Translational Control of Gene Expression
(Sonenberg, N.
, Hershey, J. W. B.
, and Mathews, M. B., eds)
, pp. 827-847, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
7.
Gonzalez, C. I.,
Bhattacharya, A.,
Wang, W.,
and Peltz, S. W.
(2001)
Gene
274,
15-25[CrossRef][Medline]
[Order article via Infotrieve]
8.
Frischmeyer, P. A.,
and Dietz, H. C.
(1999)
Hum. Mol. Genet.
8,
1893-1900 9.
Connor, A.,
Wiersma, E.,
and Shulman, M. J.
(1994)
J. Biol. Chem.
269,
25178-25184 10.
Buzina, A.,
and Shulman, M. J.
(1999)
Mol. Biol. Cell.
10,
515-524 11.
Kessler, O.,
and Chasin, L. A.
(1996)
Mol. Cell. Biol.
16,
4426-4435[Abstract]
12.
Moriarty, P. M.,
Reddy, C. C.,
and Maquat, L. E.
(1998)
Mol. Cell. Biol.
18,
2932-2939 13.
Whitfield, T. T.,
Sharpe, C. R.,
and Wylie, C. C.
(1994)
Dev. Biol.
165,
731-734[CrossRef][Medline]
[Order article via Infotrieve]
14.
Barker, G. F.,
and Beemon, K.
(1994)
Mol. Cell. Biol.
14,
1986-1996 15.
Lozano, F.,
Maertzdorf, B.,
Pannell, R.,
and Milstein, C.
(1994)
EMBO J.
13,
4617-4622[Medline]
[Order article via Infotrieve]
16.
Carter, M. S., Li, S.,
and Wilkinson, M. F.
(1996)
EMBO J.
15,
5965-5975[Medline]
[Order article via Infotrieve]
17.
Qian, L., Vu, M. N.,
Carter, M. S.,
Doskow, J.,
and Wilkinson, M. F.
(1993)
J. Immunol.
151,
6801-6814[Abstract]
18.
Carter, M. S.,
Doskow, J.,
Morris, P., Li, S.,
Nhim, R. P.,
Sandstedt, S.,
and Wilkinson, M. F.
(1995)
J. Biol. Chem.
270,
28995-29003 19.
Li, S.,
Leonard, D.,
and Wilkinson, M. F.
(1997)
J. Exp. Med.
185,
985-992 20.
Noensie, E. N.,
and Dietz, H. C.
(2001)
Nat. Biotechnol.
19,
434-439[CrossRef][Medline]
[Order article via Infotrieve]
21.
Kozak, M.
(1991)
J. Cell Biol.
115,
887-903 22.
Carter, M. S.,
Kuhn, K. M.,
and Sarnow, P.
(2000)
in
Translational Control of Gene Expression
(Sonenberg, N.
, Hershey, J. W. B.
, and Mathews, M. B., eds)
, pp. 615-635, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
23.
Belgrader, P.,
Cheng, J.,
and Maquat, L. E.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
482-486 24.
Dirks, W.,
Wirth, M.,
and Hauser, H.
(1993)
Gene
128,
247-249[CrossRef][Medline]
[Order article via Infotrieve]
25.
Mendell, J. T.,
Medghalchi, S. M.,
Lake, R. G.,
Noensie, E. N.,
and Dietz, H. C.
(2000)
Mol. Cell. Biol.
20,
8944-8957 26.
Gunning, P.,
Leavitt, J.,
Muscat, G., Ng, S. Y.,
and Kedes, L.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
4831-4835 27.
Wang, J.,
and Wilkinson, M. F.
(2000)
BioTechniques
29,
976-978[Medline]
[Order article via Infotrieve]
28.
Mühlemann, O.,
Mock-Casagrande, C. S.,
Wang, J., Li, S.,
Custodio, N.,
Carmo-Fonseca, M.,
Wilkinson, M. F.,
and Moore, M. J.
(2001)
Mol. Cell
8,
33-43[CrossRef][Medline]
[Order article via Infotrieve]
29.
Gudikote, J. P.,
and Wilkinson, M. F.
(2002)
EMBO J.
21,
125-134[CrossRef][Medline]
[Order article via Infotrieve]
30.
Wang, J.,
Gudikote, J. P.,
Olivas, O. R.,
and Wilkinson, M. F.
(2002)
EMBO Rep.
3,
274-279[CrossRef][Medline]
[Order article via Infotrieve]
31.
Pelletier, J.,
and Sonenberg, N.
(1988)
Nature
334,
320-325[CrossRef][Medline]
[Order article via Infotrieve]
32.
Sarnow, P.
(1989)
J. Virol.
63,
467-470 33.
Hennecke, M.,
Kwissa, M.,
Metzger, K.,
Oumard, A.,
Kroger, A.,
Schirmbeck, R.,
Reimann, J.,
and Hauser, H.
(2001)
Nucleic Acids Res.
29,
3327-3334 34.
Lykke-Andersen, J.,
Shu, M. D.,
and Steitz, J. A.
(2000)
Cell
103,
1121-1131[CrossRef][Medline]
[Order article via Infotrieve]
35.
Trono, D.,
Pelletier, J.,
Sonenberg, N.,
and Baltimore, D.
(1988)
Science
241,
445-448 36.
Meerovitch, K.,
Nicholson, R.,
and Sonenberg, N.
(1991)
J. Virol.
65,
5895-5901 37.
Pelletier, J.,
Kaplan, G.,
Racaniello, V. R.,
and Sonenberg, N.
(1988)
Mol. Cell. Biol.
8,
1103-1112 38.
Iborra, F. J.,
Jackson, D. A.,
and Cook, P. R.
(2001)
Science
293,
1139-1142 39.
Dostie, J.,
Lejbkowicz, F.,
and Sonenberg, N.
(2000)
J. Cell Biol.
148,
239-247 40.
Wilkinson, M. F.,
and Shyu, A. B.
(2001)
Bioessays
23,
775-787[CrossRef][Medline]
[Order article via Infotrieve]
41.
Shyu, A. B.,
and Wilkinson, M. F.
(2000)
Cell
102,
135-138[CrossRef][Medline]
[Order article via Infotrieve]
42.
Thermann, R.,
Neu-Yilik, G.,
Deters, A.,
Frede, U.,
Wehr, K.,
Hagemeier, C.,
Hentze, M. W.,
and Kulozik, A. E.
(1998)
EMBO J.
17,
3484-3494[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. Huntzinger, I. Kashima, M. Fauser, J. Sauliere, and E. Izaurralde SMG6 is the catalytic endonuclease that cleaves mRNAs containing nonsense codons in metazoan RNA, December 1, 2008; 14(12): 2609 - 2617. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Weischenfeldt, I. Damgaard, D. Bryder, K. Theilgaard-Monch, L. A. Thoren, F. C. Nielsen, S. E. W. Jacobsen, C. Nerlov, and B. T. Porse NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements Genes & Dev., May 15, 2008; 22(10): 1381 - 1396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Barbier, M. Dutertre, D. Bittencourt, G. Sanchez, L. Gratadou, P. de la Grange, and D. Auboeuf Regulation of H-ras Splice Variant Expression by Cross Talk between the p53 and Nonsense-Mediated mRNA Decay Pathways Mol. Cell. Biol., October 15, 2007; 27(20): 7315 - 7333. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-F. Chang, W.-K. Chan, J. S. Imam, and M. F. Wilkinson Alternatively Spliced T-cell Receptor Transcripts Are Up-regulated in Response to Disruption of Either Splicing Elements or Reading Frame J. Biol. Chem., October 12, 2007; 282(41): 29738 - 29747. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wittmann, E. M. Hol, and H.-M. Jack hUPF2 Silencing Identifies Physiologic Substrates of Mammalian Nonsense-Mediated mRNA Decay Mol. Cell. Biol., February 15, 2006; 26(4): 1272 - 1287. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. WACHTEL, B. LI, J. SPERLING, and R. SPERLING Stop codon-mediated suppression of splicing is a novel nuclear scanning mechanism not affected by elements of protein synthesis and NMD RNA, November 18, 2004; 10(11): 1740 - 1750. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Salati, W. Szeszel-Fedorowicz, H. Tao, M. A. Gibson, B. Amir-Ahmady, L. P. Stabile, and D. L. Hodge Nutritional Regulation of mRNA Processing J. Nutr., September 1, 2004; 134(9): 2437S - 2443S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Ferraiuolo, C.-S. Lee, L. W. Ler, J. L. Hsu, M. Costa-Mattioli, M.-J. Luo, R. Reed, and N. Sonenberg A nuclear translation-like factor eIF4AIII is recruited to the mRNA during splicing and functions in nonsense-mediated decay PNAS, March 23, 2004; 101(12): 4118 - 4123. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Bateman, S. Freddi, G. Nattrass, and R. Savarirayan Tissue-specific RNA surveillance? Nonsense-mediated mRNA decay causes collagen X haploinsufficiency in Schmid metaphyseal chondrodysplasia cartilage Hum. Mol. Genet., February 1, 2003; 12(3): 217 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. NATHANSON, T. XIA, and M. P. DEUTSCHER Nuclear protein synthesis: A re-evaluation RNA, January 1, 2003; 9(1): 9 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Mendell, C. M. J. ap Rhys, and H. C. Dietz Separable Roles for rent1/hUpf1 in Altered Splicing and Decay of Nonsense Transcripts Science, October 11, 2002; 298(5592): 419 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tao, W. Szeszel-Fedorowicz, B. Amir-Ahmady, M. A. Gibson, L. P. Stabile, and L. M. Salati Inhibition of the Splicing of Glucose-6-phosphate Dehydrogenase Precursor mRNA by Polyunsaturated Fatty Acids J. Biol. Chem., August 16, 2002; 277(34): 31270 - 31278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, J. I. Hamilton, M. S. Carter, S. Li, and M. F. Wilkinson Alternatively Spliced TCR mRNA Induced by Disruption of Reading Frame Science, July 5, 2002; 297(5578): 108 - 110. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||